General Description

Quoin Pharmaceuticals

Youtube Subscribe

Ticker: QNRX

Sector: Biotechnology

Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals. Maxim Group lower its price target from $15.00 to $4.00. Quoin pharmaceuticals (qnrx) to released earnings on wed Wednesday..

Extended Summary

Quoin Pharmaceuticals

Quoin Pharmaceuticals Ltd. reported a quarterly adjusted loss of $2.08 per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of $-4.92. Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Heres What You Need To Know Maxim Group has decided to maintain its Buy rating of Quoin. Maxim Group lower its price target from $15.00 to $4.00. Shares of QNRX trading up 2.0% over the last 24 hours. Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) to release earnings on wed Wednesday - defense world. quoin pharmaceuticals (qnrx) to released earnings on Wed Wednesday. Quoin Pharmaceuticals Ltd - ADR (QNRX) is up 5.00% friday in premarket trading. In the Biotechnology industry, which ranks 99 out of 146 industries, the stock ranks higher than 16% of stocks. The company has reported EPS of $774.71.

Related Results

March 17, 2024 1:59 (London Time)